1. Laparoscopic versus Open Cytoreductive Nephrectomy in Advanced Renal-Cell Carcinoma
- Author
-
Viraj A. Master, Christopher J. Kane, Manuel S. Eisenberg, Maxwell V. Meng, Brian I. Rini, Peter R. Carroll, and Marshall L. Stoller
- Subjects
Male ,medicine.medical_specialty ,Urology ,medicine.medical_treatment ,Nephrectomy ,Renal cell carcinoma ,medicine ,Carcinoma ,Humans ,Carcinoma, Renal Cell ,Retrospective Studies ,Performance status ,business.industry ,Perioperative ,Middle Aged ,medicine.disease ,Kidney Neoplasms ,Surgery ,Treatment Outcome ,Female ,Laparoscopy ,business ,Packed red blood cells ,Kidney cancer ,Kidney disease - Abstract
There is growing evidence of the benefit of cytoreductive nephrectomy prior to immunotherapy in patients with advanced renal-cell carcinoma (RCC). We compared the outcomes of patients with metastatic RCC undergoing laparoscopic and open cytoreductive nephrectomy prior to systemic therapy.We retrospectively analyzed 27 patients undergoing cytoreductive nephrectomy for metastatic RCC between 2000 and 2004, 16 laparoscopically and 11 by an open approach. Patients with inferior vena-caval tumor thrombus were excluded from analysis. The two groups were comparable with regard to tumor size, clinical stage, and performance status. Surgical, pathologic, and perioperative characteristics and outcomes were compared.The laparoscopic technique was associated with reduced blood loss (149 v 1135 mL; P = 0.03), transfusion rate and quantity (13% v 55%; P = 0.03; 0.13 v 2.0 units of packed red blood cells; P = 0.007), shorter time to oral intake (1.2 v 2.7 days; P0.001), and shorter hospitalization (3.6 v 6.8 days; P0.001) compared with open nephrectomy. No significant differences were observed with respect to pathologic stage, operative time, complications, fraction receiving subsequent systemic therapy, time to systemic therapy, or survival.Laparoscopic cytoreductive nephrectomy is associated with reduced morbidity and hospital stay compared with open surgery. There was no increase in complications, and the ability to proceed with subsequent systemic therapy was maintained in the majority of patients. The laparoscopic approach can be considered in patients with metastatic RCC as part of a cytoreductive and systemic-therapy regimen.
- Published
- 2006